Full-Time
Posted on 11/1/2025
Delivers value-based care through analytics
No salary listed
Pune, Maharashtra, India
Remote
| , |
Evolent Health helps healthcare organizations transition to value-based care by pairing technology, analytics, and clinical expertise to improve patient outcomes while lowering costs. It partners with health systems, physician groups, and health plans to deliver data-driven care coordination, population health management, and risk-adjustment services. The company’s offerings include software platforms, analytics, and clinical support that enable more efficient care delivery, shared savings programs, and performance-based incentives. Compared with competitors, Evolent emphasizes end-to-end collaboration with clients and a diversified client base, combining technology with hands-on clinical and operational expertise to drive measurable outcomes. Its goal is to help clients succeed in value-based models by delivering better patient care at lower total costs.
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Arlington, Virginia
Founded
2011
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Flexible Work Hours
Hybrid Work Options
Performance Bonus
Evolent Health has appointed Archie Mayani as chief product officer. Mayani brings over 20 years of experience in healthcare technology and AI innovation from roles at GHX, Change Healthcare, UnitedHealth Group and Amazon. Most recently, Mayani served as CPO at GHX, where she developed AI-powered capabilities for healthcare supply chains. At Change Healthcare, she led clinical decision support and revenue cycle platforms, focusing on reducing administrative burden in prior authorisation. During her time at Optum and UnitedHealth Group, she scaled value-based care programmes that improved Medicare STARS performance and reduced hospital utilisation. Mayani also served as global head of product and content operations for Amazon Prime Video. She has received multiple industry honours, including the Global CPO Award in 2025 and Inspiring Leader Award in 2023.
Evolent Health faces a shifting investment narrative after analysts reset expectations, with fair value estimates dropping from $8.50 to $5.18. The revision reflects concerns about reserves, leverage and margin visibility. Despite lowered price targets, Oppenheimer, BTIG, UBS, Citi, Truist and Canaccord maintain positive ratings, citing conservative reserving and new contracts as potential margin support. Analysts view new CFO Mario Ramos as bringing increased transparency. However, KeyBanc downgraded to Sector Weight, highlighting leverage at approximately 7x and limited EBITDA recovery visibility. Multiple firms reduced 2026-2028 earnings assumptions amid medical cost pressures and ACA exchange membership concerns. Evolent recorded a $398 million goodwill impairment for Q4 2025 and issued 2026 revenue guidance of $2.4 billion to $2.6 billion.
Evolent Health shares surged 20.7% after the healthcare solutions company reported fourth-quarter earnings that beat expectations and issued optimistic revenue guidance. The company posted non-GAAP earnings of $0.08 per share, significantly improved from a $0.02 per share loss a year earlier and ahead of analyst forecasts. Whilst quarterly revenue fell 27.5% year-on-year to $468.7 million, meeting expectations, investors focused on strong future guidance. Evolent projected full-year 2026 revenue between $2.4 billion and $2.6 billion, with the midpoint suggesting approximately 30% growth and nearly 5% above analyst estimates. The shares are trading at $3.15, down 19.2% year-to-date and 73.3% below their 52-week high of $11.79 from July 2025.
Privia Health acquires Evolent's ACO business to boost value-based care.
Privia Health is acquiring a value-based primary care business from Evolent Health as the physician enablement company continues to expand its care delivery network into new geographies.